logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Biodrugs cover

Biodrugs

IF6.9
Papers1584
Citations3462
Journal Papers 1677
Publication Date
delete
From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate
deleteBiodrugs
IF6.9
delete2026-09-19
delete0
deleteOAAI
deleteBjörn Capsius; Marija Pesic; Ravil Niyazov; Susanne Pippig; Michael Trieb; Rahul Hole; Sigrid Balser; Andreas Seidl
deleteShare
deleteSave
Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects
deleteBiodrugs
IF6.9
delete2026-09-17
delete0
PREAI
deleteQiang Chen
deleteShare
deleteSave
HLX11: A Pertuzumab Biosimilar
deleteBiodrugs
IF6.9
delete2026-09-17
delete0
PREAI
deleteAisling McGuigan
deleteShare
deleteSave
Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk
deleteBiodrugs
IF6.9
delete2026-09-14
delete0
deleteOAAI
deleteTed R. Mikuls; Tuhina Neogi; Angelo Gaffo
deleteShare
deleteSave
Biosimilars: A Virtuous Cycle of Sustainability and Innovation
deleteBiodrugs
IF6.9
delete2026-09-14
delete0
deleteOAAI
deleteFernando de Mora; Vicente Merino-Bohórquez; Rosario García-Vicuña; Isabel Río-Álvarez
deleteShare
deleteSave
Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases
deleteBiodrugs
IF6.9
delete2026-09-14
delete0
deleteOAAI
deleteLiyan Qiu; Jonas Torbjörn Ungerbäck; Eric Paul Bennett; Rasmus O. Bak
deleteShare
deleteSave
The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease
deleteBiodrugs
IF6.9
delete2026-09-11
delete0
deleteOAAI
deleteMartha Caterina Faraguna; Daniël A. M. Lambregts; Ina Barzel; Edwin H. Jacobs; Marianne Hoogeveen-Westerveld; Nadine A. M. E. van der Beek; W. W. M. Pim Pijnappel; Serena Gasperini; Tim Preijers; Johanna M. P. van den Hout; Ans T. van der Ploeg
deleteShare
deleteSave
Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability
deleteBiodrugs
IF6.9
delete2026-09-02
delete0
deleteOAAI
deleteLourdes Sainero-Alcolado; Dilraj Lama; Mohammad Alzrigat; Marie Arsenian-Henriksson
deleteShare
deleteSave
Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial
deleteBiodrugs
IF6.9
delete2026-08-28
delete0
PREAI
deleteOh Chan Kwon; Soo Min Ahn; Seokchan Hong; Yeon Hong Seo; Min Kim; Joo Yong Lee; Un Chul Park; Seong Joon Ahn; Min-Chan Park; Eun Young Lee; Tae-Hwan Kim; Yong-Gil Kim
deleteShare
deleteSave
Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape
deleteBiodrugs
IF6.9
delete2026-08-18
delete0
deleteOAAI
deleteDario Roccatello; Savino Sciascia; Daniela Rossi; Roberta Fenoglio
deleteShare
deleteSave
Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study
deleteBiodrugs
IF6.9
delete2026-08-03
delete0
PREAI
deleteXin Ma; Yue Jiang; Dongmei Liu; Quanruo Xu; Fanlingzi Shen; Zhen Duan; Xiangjin Gao; Xiuqi Zhang; Ruiqi Cai; Rui Zhang; Bin Li; Ruiping Wang
deleteShare
deleteSave
Population Pharmacokinetic Comparability of CT-P16 Versus EU-Avastin® and US-Avastin® in Healthy Subjects and Patients with Non-Squamous Non-Small Cell Lung Cancer
deleteBiodrugs
IF6.9
delete2026-08-02
delete0
deleteOAAI
deleteTaekyung Kim; Heungjo Kim; Hongjae Lee; Keumyoung Ahn; Taehong Park; Hyungseok Baek; Min Jung Chang
deleteShare
deleteSave
Expanding Patient Access to Advanced Therapies
deleteBiodrugs
IF6.9
delete2026-07-21
delete0
deleteOAAI
deleteElena Guillen; Ana Hidalgo-Simon
deleteShare
deleteSave
Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes
deleteBiodrugs
IF6.9
delete2026-07-20
delete0
deleteOAAI
deleteImke A. M. Ditters; Hidde H. Huidekoper; Jacqueline F. Hardon; Michelle E. Kruijshaar; Ans T. van der Ploeg; Johanna M. P. van den Hout
deleteShare
deleteSave
Why Product Drift Is Not an Issue for Biosimilars/Biologics: Start the Same, Stay the Same
deleteBiodrugs
IF6.9
delete2026-07-08
delete0
deleteOAAI
deleteJoseph P. Park; Hyunhee Oh; Gillian R. Woollett
deleteShare
deleteSave
Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis
deleteBiodrugs
IF6.9
delete2026-07-02
delete0
PREAI
deleteCarlos Roberto Montes-de-Oca-Saucedo; Laura Ghanem; Najwaa Kirmani; Bruno Briceño-Villardaga; Andrea Michelle Talancon-Solana; Adela Jatzari Salinas-Ocampo; Grecia Sereno-Acevedo; Adolfo Soto-Domínguez; Raquel Rivera-Díaz
deleteShare
deleteSave
Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
deleteBiodrugs
IF6.9
delete2026-07-01
delete0
deleteOAAI
deleteZhihua Ran; Yan Chen; Yinglei Miao; Yufang Wang; Xiang Gao; Jie Zhong; Xueli Ding; Chengdang Wang; Xiaolan Zhang; Yijuan Ding; Naizhong Hu; Dan Tang; Jiao Yu; Chenxi Qian; Jun Shen
deleteShare
deleteSave
Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities
deleteBiodrugs
IF6.9
delete2026-06-25
delete0
deleteOAAI
deleteRebecca J. Wilson; Charmaine A. Ramlogan-Steel; William J. Deasy; Sarah J. Greenstein; Christopher J. Layton; Jason C. Steel
deleteShare
deleteSave
An Overview and Trend Analysis of Biosimilar Approvals in China
deleteBiodrugs
IF6.9
delete2026-06-17
delete0
PREAI
deleteMei Yang; Ning Zhang; Haixue Wang
deleteShare
deleteSave
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab
deleteBiodrugs
IF6.9
delete2026-06-17
delete0
deleteOAAI
deleteAnika M. Valk; Jolinde van Strien; Ninotska Derksen; Dorien Kos; Júlia Castellon Teixell; Jerry Janssen; Floris C. Loeff; Lisanne Dijk; Maureen Leeuw; Catherine Smith; Teresa Tsakok; Richard Warren; Nick J. Reynolds; Christopher E. M. Griffiths; Jonathan Barker; Robert Rissman; Wouter ten Voorde; Justin Jacobse; Daniel Alvarez; Marieke van Ham; Gertjan Wolbink; Anja ten Brinke; Theo Rispens
deleteShare
deleteSave